Our core team

DR.GERHARD HAWA
Founder & CEO
Gerhard Hawa is a biochemist and has spent most of his career developing diagnostic tests. Several patents document the combination of creativity and expertise. Gerhard Hawa has held several positions as CEO in the healthcare sector and founded Fianostics GmbH in 2014.
DR. ALBERT MISSBICHLER
Co-founder & Partner
Albert Missbichler is also a biochemist with over thirty years of experience in clinical diagnostics in various management positions. Albert Missbichler has been involved in various companies as a business angel since a successful exit.
DI JOSEF SCHABAUER
Partner
Josef Schabauer, a graduate of the University of Natural Resources and Life Sciences, brings decades of experience as Managing Director and Business Development in the healthcare industry, mainly at Abbott Laboratories. Josef Schabauer is an internationally well-connected and strongly results-orientated entrepreneur with a high level of expertise and analytical skills.

Advisory Board

Dr. Frank Middleton
Dr Frank Middleton is a Professor in the Departments of Neuroscience, Biochemistry, Psychiatry and Pediatrics at SUNY Upstate Medical University, where he also directs the SUNY Molecular Analysis Core Facility. Dr Middleton's research uses high-throughput multi-omic approaches to profile and discover biomarkers for neuro-developmental, neuropsychiatric and neuro-degenerative disorders, including autism spectrum disorder (ASD), Parkinson's disease (PD) and mild traumatic brain injury (mTBI).
Luc Ruyson
Luc Ruyson served as DVP International Commercial Operations and Global Strategic Marketing at ABBOTT Diagnostics until 2018. He now lives and works in Florida as a Health Care Executive Consultant

FIANOSTICS presents a completely new generation of fluorescence assays developed and produced in Austria, patented worldwide

WordPress Cookie Plugin by Real Cookie Banner